The 3rd DHR-ICMR Health Research Excellence Summit highlighted India's medical research progress, with 100 technology transfer deals, new health initiatives and participation from over 600 experts.
The Indian Council of Medical Research (ICMR) marked a major achievement in India's healthcare research and innovation sector by completing 100 successful technology transfer deals. The milestone was announced during the 3rd Department of Health Research (DHR)-ICMR Health Research Excellence Summit, organised at Bharat Mandapam in New Delhi on November 16 and 17, 2026.
The two-day summit brought together more than 600 participants, including scientists, medical researchers, innovators, healthcare professionals and policymakers. The event provided a platform to discuss developments in biomedical research, encourage collaboration and explore ways to convert scientific discoveries into practical healthcare solutions.
The summit also marked 115 years of ICMR's contribution to biomedical science and health research in India, highlighting the organisation's long-standing role in advancing medical knowledge and supporting public health initiatives.
One of the most significant announcements at the summit was ICMR's achievement of 100 technology transfer agreements. The milestone was reached in less than two years after the launch of the Medical Innovations Patent Mitra initiative.
During the Technology Transfer Ceremony, ICMR exchanged 20 licensing agreements covering eight technologies with nine Indian companies. These agreements are intended to facilitate the transfer of research-based technologies from scientific institutions to industry partners.
The collaboration provides a pathway for converting innovations developed through medical research into products and solutions that can be taken forward for wider application.
Medical Innovations Patent Mitra is a flagship initiative launched by Union Minister of Health and Family Welfare Jagat Prakash Nadda in March 2025.
The initiative aims to strengthen the process of transferring medical innovations and intellectual property to industry. It helps create connections between research institutions and companies that can support the development, commercialisation and practical use of healthcare technologies.
Reaching 100 agreements within less than two years reflects the growing engagement between ICMR and Indian companies in bringing research outcomes closer to real-world applications.
An Innovation Exhibition was another important feature of the summit. It displayed 17 indigenous technologies developed by ICMR institutes and their partner institutions.
The exhibition highlighted research-driven solutions created within India's scientific ecosystem. It also offered an opportunity for participants to understand the work being undertaken by domestic research organisations in the healthcare and biomedical fields.
By bringing researchers, innovators and policymakers together, the exhibition encouraged discussions around the practical application of these technologies and the potential for collaboration with industry.
The showcase also reinforced the importance of developing home-grown medical technologies to address healthcare challenges and strengthen India's research and innovation capabilities.
The summit witnessed the launch of three initiatives aimed at improving the connection between medical research, public health policy, disease surveillance and academic opportunities.
The Department of Health Research introduced the Research to Action Vertical to help translate scientific evidence into practical outputs for government policies and programmes.
The initiative will focus on converting research findings into decision-ready products that can support policymakers and programme administrators. Its objective is to make scientific evidence more useful in planning and implementing public health interventions.
This approach can help bridge the gap between research activities and the decisions required to address healthcare priorities.
Another initiative announced at the summit was Syndromic Surveillance under the Virus Research and Diagnostic Laboratories (VRDL) Scheme.
The programme aims to establish an early-warning network for detecting potential disease outbreaks through 70 laboratories.
A coordinated surveillance system can help identify unusual disease patterns and provide early signals of emerging public health threats. Such information can support timely monitoring, investigation and response by relevant health authorities.
The initiative is expected to strengthen India's disease surveillance capabilities by connecting participating laboratories through a structured monitoring network.
The third initiative was the Dr. M. K. Bhan Young Medical Faculty PhD Portal. It will function as a centralised digital platform for prospective applicants.
The portal is intended to make information and access related to PhD opportunities more organised for young medical faculty members and applicants. A centralised digital system can simplify the application process and improve access to relevant academic opportunities.
The initiative also reflects the importance of developing research talent and encouraging greater participation in medical and biomedical research.
ICMR also released its Antimicrobial Resistance (AMR) Annual Report and Standard Operating Procedures (SOPs) during the summit.
Antimicrobial resistance is a major public health concern because it reduces the effectiveness of medicines used to treat infections. Monitoring resistance patterns and following standard procedures are important for improving the understanding and management of this challenge.
The release of the annual report and SOPs provides research and healthcare stakeholders with information and procedural guidance related to antimicrobial resistance.
These resources can support more consistent research, surveillance and monitoring activities across relevant institutions.
The summit also recognised young contributors to public health by honouring the top 100 school students selected through the SHINE National Competition.
The recognition highlighted the importance of involving students in public health awareness and encouraging early interest in health-related issues.
By acknowledging their contributions, the initiative aimed to encourage young people to participate in activities that support public health and community well-being.
The 3rd DHR-ICMR Health Research Excellence Summit highlighted progress across several areas of India's healthcare research ecosystem. The completion of 100 technology transfer deals demonstrated the growing interaction between research institutions and Indian industry.
The exchange of 20 licensing agreements, display of 17 indigenous technologies and launch of three new initiatives further underlined the focus on translating scientific knowledge into practical applications.
The summit's emphasis on disease surveillance, antimicrobial resistance, research-based policymaking and young researchers also reflected the wide-ranging priorities of India's health research sector.
As ICMR completes 115 years of contribution to biomedical and health research, these developments underline the importance of collaboration, innovation and scientific evidence in strengthening India's healthcare system.